The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-tumor activity of CoREST inhibitor, JBI-802 (dual epigenetic modifier of LSD1/HDAC6): An opportunity to treat essential thrombocythemia and MPN/MDS patients with thrombocytosis in ongoing phase 1/2 clinical trial.
 
Melda Dolan
Employment - Jubilant DraxImage
 
Sridharan Rajagopal
Employment - Jubilant Therapeutics India Limited
 
Abhijit B
Employment - Jubilant DraxImage
 
Deepak Mittal
Employment - Jubilant Therapeutics India Limited
 
Shawnavaz Vazeer
Employment - Jubilant Therapeutics India Limited
 
Mohd Zainuddin
Employment - Jubilant Therapeutics
 
G Chandru
Employment - Jubilant Therapeutics
 
Naveen Sadhu
Employment - Jubilant Therapeutics
 
Syed Kazmi
Employment - Jubilant Therapeutics
Leadership - Jubilant Therapeutics